Navigation Links
Elekta appoints Niklas Savander as its next President and Chief Executive Officer
Date:10/25/2013

STOCKHOLM, Oct. 25, 2013 /PRNewswire/ -- Elekta announced today that Niklas Savander has been appointed as its next President and Chief Executive Officer, effective May 1, 2014. Niklas Savander will succeed Tomas Puusepp, who will continue with Elekta as a working member of its Board of Directors per the same date.

(Photo: http://photos.prnewswire.com/prnh/20131025/CL04205)

Niklas Savander has extensive experience from senior management positions both within Hewlett Packard and Nokia, most recently as a member of Nokia's Executive Management Team responsible for the Company's day-to-day operations. He is currently a Private Equity Adviser in Helsinki, Stockholm and London.  Mr. Savander is married and has two children.

Laurent Leksell, Elekta's founder, former CEO and Chairman of the Board of Directors, commented: "We are very pleased to have been able to appoint such an experienced and capable executive as Niklas Savander. His deep understanding of complex global technology industries, as well as his experience from global markets, is uniquely suited to lead Elekta through our next phase of profitable growth."

Commenting on Tomas Puusepp, Laurent Leksell said: "Tomas Puusepp has done a more than outstanding job as CEO. Under his leadership, Elekta has become a full-service Radiation Therapy company with the ambition to become the market leader in the next couple of years. I am pleased that Tomas has decided to continue working for Elekta as full-time member of the Board of Directors."

Niklas Savander
'/>"/>

SOURCE Elekta
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Private Hospital Group in Spain Expands Radiotherapy Capabilities with Countrys First Elekta Versa HD System
2. Nucletron, an Elekta Company, Receives U.S. FDA 510(k) Clearance for Esteya Electronic Brachytherapy System for Treating Skin Cancer
3. Elekta Announces Monaco 5.0 -- Comprehensive Radiation Treatment Planning Capabilities Brought Together in One System
4. New Elekta Radiation Therapy Technology Takes Weeks Off of Lung Cancer Treatments
5. Switzerlands Hopital Riviera Improves Confidence in Patient Treatment with Elektas Identify Solution
6. Elekta to Spotlight Versa HD System at 2013 ASTRO Annual Meeting
7. Elekta Introduces Groundbreaking Image Guidance Capabilities Integrated with Versa HD Cancer Treatment System
8. Johns Hopkins Kimmel Cancer Center Acquires Elekta Versa HD System
9. Elektas Leksell Gamma Knife Perfexion and Elekta Infinity Place First and Second in 2013 KLAS Radiation Therapy Report
10. Elekta to Exhibit New Versa HD Radiotherapy System at Annual Radiation Physics Conference
11. Odense Universitetshospital tilfører kræftpatienters stereotaktiske strålebehandling næsten tre gange hurtigere med Elektas Versa HD-system
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... SAN FRANCISCO , June 29, ... company,s novel blood-draw technology has received CE Mark ... quality from the European Union. This regulatory milestone ... alternative to one of the most common procedures ... Velano Vascular,s proprietary device reduces the ...
(Date:6/29/2015)... , June 29, 2015 ... and predicted revenues ,Where is the market for dermatological ... market? Visiongain ,s new report shows you potential ... and prospects. Our 310 page report ... most lucrative areas in the industry and the future ...
(Date:6/29/2015)... Calif. , June 29, 2015  The ... innovative features to cars on the basis of ... The industry is now on the verge of ... cars. While automotive HWW non-critical features such as ... be present in 30 to 40 percent of ...
Breaking Medicine Technology:Velano Vascular Receives CE Mark For Novel Blood Draw Technology Designed to Reduce Needle Exposures for Hospitalized Patients and Healthcare Providers 2Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 2Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 3Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 4Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 5Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 6Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 7Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 8Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 2Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 3Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 4
... Expected in November 2008, BOTHELL, Wash., Oct. 9 ... the completion of patient enrollment and dosing,for the third ... and,efficacy of its formulation of 12-hour extended-release (ER) ibuprofen ... top-line,results from this pivotal trial in November 2008. Ibuprofen ...
... Will Reduce Animal Use in Cosmetics and Chemicals ... Corp. today announced,that results of a recently completed ... EpiDerm in vitro human skin tissue,equivalent. The test ... to be accepted as a validated alternative to ...
Cached Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2
(Date:6/29/2015)... ... June 29, 2015 , ... Mediaplanet has released the ... USA TODAY. This 12-page, glossy, full-color special section hit newsstands Friday, June 26th, ... totaling approximately 450,000 copies, with an estimated readership of 1.3 million. The digital ...
(Date:6/29/2015)... ... June 29, 2015 , ... Brittenford Systems, a provider ... other growing businesses across the United States, has announced that it has been ... fifth consecutive year. , Based on company revenue and number of employees, Bob ...
(Date:6/29/2015)... , ... June 29, 2015 , ... ... developed a new approach to build nearly complete genomes by combining high-throughput DNA ... genomic variation, critically important for their association with human disease, but previously difficult ...
(Date:6/29/2015)... (PRWEB) , ... June 29, 2015 , ... San ... to lift and tighten sagging skin. Ulthera is a special treatment that offers a ... uses ultrasound technology to gently stimulate collagen production. Ulthera is highly targeted and precise ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... Biology and Chemical Technology of The Hong Kong Polytechnic University (PolyU) has developed ... oils. Authentication of edible oils has been a long-term issue in food safety, ...
Breaking Medicine News(10 mins):Health News:Mediaplanet partners with USA TODAY and Kris Letang to raise awareness about the risk of heart attack and stroke 2Health News:Brittenford Systems Celebrates Fifth Consecutive Year on Bob Scott Insights Top 100 VARs 2Health News:Brittenford Systems Celebrates Fifth Consecutive Year on Bob Scott Insights Top 100 VARs 3Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 2Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 3Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 4Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 2Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 3Health News:PolyU develops a new method for rapid authentication of edible oils and screening of gutter oils 2
... mammograms are more likely to interpret a benign growth ... and experience," and CAD systems do not help detect ... systems use complex algorithms to identify "suspicious" areas of ... which cost $50,000 to $175,000, were approved by FDA ...
... were the biggest killers. Now it appears that the ravage ... the fatalities caused by road accidents. , ... of Edinburgh, has provided statistics which demonstrates the increase in ... in contrast, MRSA cases had dropped by 4.3 per cent. ...
... University, has found a mutation in a single gene that ... among dog breeds and probably is important in determining the ... the April 6 issue of the journal Science, "is one ... dog breeds that share the same trait (such as large ...
... nations is undermining essential health services, including treatments for ... Margaret Chan said on Tuesday in Singapore ahead of ... of health care professionals have left their homes in ... wealthier countries, Reuters reports. ,According to WHO's ...
... African nation and very poor, has banned the life-threatening practice ... ,Anybody involved in female genital mutilation (FGM) would ... ,The move follows a campaign against the practice ... than 90% of Eritrean women are circumcised. ...
... and routine walks could ease uncomfortable symptoms and help women ... ,Menopause is the time in a woman's life when ... occurs naturally, most often after age 45. ... the health of more than 160 women, dividing them into ...
Cached Medicine News:Health News:Researchers Identify Gene That Plays Key Role in Size of Dogs -- and Probably in Humans 2Health News:Eritrea Bans Female Circumcision 2
... A concentrated enzymatic cleanser ... semi-automated hematology instruments. It ... all Abbott CELL-DYN® hematology ... instruments. The shelf life ...
Streck-CD3500 Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the Abbott CELL-DYN® 3500 and 3700. The shelf life is two years from the date of manufacture....
Streck-Diluent III Plus is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 3000, 3500 and 3700. The shelf...
Streck-Diluent IIIA is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 1700. The shelf life is one year f...
Medicine Products: